Biomarin Pharmaceutical Inc : Biomarin announces public offering of common stock .Says offering of 7.5 million shares of its common stock in an underwritten public offering.
The stock increased 0.71% or $0.46 during the last trading session ... which manages about $932.59M and $348.77 million US Long portfolio, upped its stake in Biomarin Pharmaceutical Inc (NASDAQ:BMRN) by 21,626 shares to 35,281 …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BMRN at https://www.zacks.com/ap/BMRN Keywords: BioMarin
Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $79.36 to a high of $82.57. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $82.11 on volume of 655,000 …
* Biomarin Pharmaceuticals says expects to begin shipping just approved Brineura within 6 weeks * Biomarin says expected annual cost for Brineura to be $486,000 for ultra-rare pediatric brain disease * Biomarin says will have co-pay …
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site …
Fox 82mon
BioMarin Pharmaceutical shared some amazing news last week when they revealed that their new experimental drug to treat dwarfism showed a 50% growth increase among the children receiving the highest doses in a preliminary study. …